Home Biosimilar Antibodies Immunology & Inflammation PD-1/PD-L1 Pimivalimab (Anti-PDCD1 / PD-1 / CD279)
For research use only. Not for use in humans.

Pimivalimab (Anti-PDCD1 / PD-1 / CD279)

Synonyms: JTX-4014

Pimivalimab (Anti-PDCD1 / PD-1 / CD279) is human monoclonal antibody targeting human cell receptor programmed cell death protein 1 (PD-1; PDCD1; CD279). It can be used for the research of solid tumor. MW :144.5 KD.

Pimivalimab (Anti-PDCD1 / PD-1 / CD279)

Quality Control

  • Cited in Nature Medicine for its top-tier quality
  • SDS
  • Datasheet

Specificity

Name Citation PD-1/PD-L1 interaction PD-1 PD-L1 PD-1/PD-L1 Others
GS-4224 0
INCB086550 1
BMS-1001 0
BMS-1166 8
PD-1/PD-L1 Inhibitor 3 13
BMS-1 13
BMS-202 26
CA-170 (AUPM-170) 0
SR 0987 1 IL17,RORγt
Spartalizumab (anti-PD-1) 3
Camrelizumab (anti-PD-1) 2
AUNP-12 3
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Pimivalimab (Anti-PDCD1 / PD-1 / CD279) is human monoclonal antibody targeting human cell receptor programmed cell death protein 1 (PD-1; PDCD1; CD279). It can be used for the research of solid tumor. MW :144.5 KD.
References

Product Details

CAS No. 2293951-22-9
Isotype Human IgG4SP
Source CHO
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.